Abstract
The paraventricular nucleus (PVN) of the hypothalamus is involved in tonic regulation of sympathetic outflow. Impaired GABAergic control of PVN neurons may contribute to the elevated sympathetic drive in hypertension. In this study, we examined the function of GABAA and GABAB receptors in the PVN in control of sympathetic nerve activity and arterial blood pressure (ABP) in normotensive and hypertensive rats. Lumbar sympathetic activity (LSNA) and ABP were recorded from anesthetized spontaneously hypertensive rats (SHRs), Sprague-Dawley (SD) rats, and Wistar-Kyoto (WKY) rats. Bilateral microinjection of bicuculline (0.01–0.15 nmol), a GABAA receptor antagonist, into the PVN increased LSNA and ABP in normotensive WKY and SD rats in a dose-dependent manner. This response was significantly attenuated in SHRs. Furthermore, the decrease in LSNA and ABP induced by a GABAA receptor agonist, muscimol (0.05–1.5 nmol), in the PVN was significantly less in SHRs than in normotensive controls. In contrast, microinjection of the GABAB receptor agonist baclofen (0.3–4.5 nmol) into the PVN decreased LSNA and ABP in SHRs. However, in WKY and SD rats, baclofen only decreased LSNA and ABP at the highest dose tested. In addition, blockade of GABAB receptors in the PVN with CGP52432 (3-[[(3,4-dichlorophenyl)methyl]amino]propyl]diethoxymethyl)phosphinic acid) (0.15–3.0 nmol) dose-dependently increased LSNA and ABP in SHRs but not in normotensive controls. Collectively, this study provides new evidence that GABAA receptor function is attenuated, whereas the function of GABAB receptors is enhanced, in the PVN of SHRs.
Footnotes
-
This work was supported by the National Institutes of Health (Grants HL60026 and HL77400) and by a Beginning Grant-in-aid from the American Heart Association, Pennsylvania-Delaware Affiliate.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.106.109538.
-
ABBREVIATIONS: SHR, spontaneously hypertensive rat; PVN, paraventricular nucleus; SD, Sprague-Dawley; ABP, arterial blood pressure; RVLM, rostral ventrolateral medulla; WKY, Wistar-Kyoto; HR, heart rate; LSNA, lumbar sympathetic nerve activity; CGP52432, 3-[[[[(3,4-dichlorophenyl)methyl]amino]propyl]diethoxymethyl]phosphinic acid; bpm, beats per minute.
- Received June 16, 2006.
- Accepted October 26, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|